The Scientist

» clinical trials and immunology

Most Recent

image: Updated Review: Tamiflu Is a Bust

Updated Review: Tamiflu Is a Bust

By | April 10, 2014

After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.

6 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: Epigenetic Cancer Therapy Clears Phase I

Epigenetic Cancer Therapy Clears Phase I

By | April 7, 2014

Investigational drug that inhibits proteins involved with epigenetic regulation shows activity against certain blood cancers in an early-stage clinical trial.

0 Comments

image: Commander of an Immune Flotilla

Commander of an Immune Flotilla

By | April 1, 2014

With much of his early career dictated by US Navy interests, Carl June drew inspiration from malaria, bone marrow transplantation, and HIV in his roundabout path to a breakthrough in cancer immunotherapy.

1 Comment

image: Deploying the Body’s Army

Deploying the Body’s Army

By | April 1, 2014

Using patients’ own immune systems to fight cancer

3 Comments

image: Making Better Mesenchymal Stem Cells

Making Better Mesenchymal Stem Cells

By | March 27, 2014

Scientists generate a new crop of stem cells that show therapeutic potential in mouse models of autoimmune diseases.

0 Comments

image: Vitamin A’s Influence on Immunity

Vitamin A’s Influence on Immunity

By | March 19, 2014

Exposure to vitamin A in the womb influences immune system development and lifelong ability to fight infections, a mouse study shows. 

1 Comment

image: Saving Failing Hearts

Saving Failing Hearts

By | March 12, 2014

Inhibiting a small regulatory RNA appears to improve cardiac function in mice with surgically induced heart problems.

0 Comments

image: FDA Considers Three-Way Babies

FDA Considers Three-Way Babies

By | February 26, 2014

The agency is soliciting opinions on a new technology that has the potential to circumvent mitochondrial diseases by producing embryos using DNA from three people.

1 Comment

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

Popular Now

  1. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  2. An Aging-Related Effect on the Circadian Clock
  3. Marching for Science, from Berlin to Sydney
  4. Opinion: Is a Clone Really Born at Age Zero?
Business Birmingham